Schistosoma: Difference between revisions

From IDWiki
Schistosoma
Content deleted Content added
No edit summary
Line 3: Line 3:
== Species ==
== Species ==


* ''S. mansoni'': liver and gut
* ''[[Schistosoma mansoni]]'': liver and gut
* ''S. haematobium'': GU/pelvis
* ''[[Schistosoma haematobium]]'': GU/pelvis
* ''S. japonicum'': liver and gut
* ''[[Schistosoma japonicum]]'': liver and gut
* ''S. mekongi'': Mekong basin
* ''[[Schistosoma mekongi]]'': Mekong basin


== Risk Factors ==
== Risk Factors ==

Revision as of 18:42, 10 December 2019

  • Infection with a species of the genus Schistosoma

Species

Risk Factors

  • Fresh water exposure in endemic countries

Clinical Presentation

Investigations

  • Labs
    • CBC, showing eosinophilia
    • Schisto serology (only positive 6 weeks after infection)
    • Egg detection in stool, urine, semen, or tissue biopsy
  • Imaging
    • Eggs can cause granulomatous disease in various organs
    • Bladder polyps and obstruction may be seen on ultrasound

Management

  • Acute
    • Praziquantel 40mg/kg/d
      • Can cause nausea, dizziness, and fever
  • Chronic
    • Prevention

Prognosis

  • Increased risk of squamous cell carcinoma, which increase with young age at infection, duration of infection, high burden of infection, and bladder wall fibrosis

References

  1. ^  Archana Asundi, Alina Beliavsky, Xing Jian Liu, Arash Akaberi, Guido Schwarzer, Zeno Bisoffi, Ana Requena-Méndez, Ian Shrier, Christina Greenaway. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. The Lancet Global Health. 2019;7(2):e236-e248. doi:10.1016/s2214-109x(18)30490-x.
  2. ^  Daniela Knafl, Christian Gerges, Charles H. King, Marc Humbert, Amaya L. Bustinduy. Schistosomiasis-associated pulmonary arterial hypertension: a systematic review. European Respiratory Review. 2020;29(155):190089. doi:10.1183/16000617.0089-2019.
  3. ^  Michelle K. Yong, Carolyn L. Beckett, Karin Leder, Beverley A. Biggs, Joseph Torresi, Daniel P. O’Brien. Long‐Term Follow‐Up ofSchistosomiasisSerology Post‐Treatment in Australian Travelers and Immigrants. Journal of Travel Medicine. 2010;17(2):89-93. doi:10.1111/j.1708-8305.2009.00379.x.